281 related articles for article (PubMed ID: 28442256)
1. Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties.
Mateeva N; Eyunni SVK; Redda KK; Ononuju U; Hansberry TD; Aikens C; Nag A
Bioorg Med Chem Lett; 2017 Jun; 27(11):2350-2356. PubMed ID: 28442256
[TBL] [Abstract][Full Text] [Related]
2. Exploration of (hetero)aryl Derived Thienylchalcones for Antiviral and Anticancer Activities.
Patil V; Patil SA; Patil R; Bugarin A; Beaman K; Patil SA
Med Chem; 2019; 15(2):150-161. PubMed ID: 29792154
[TBL] [Abstract][Full Text] [Related]
3. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
Loa J; Chow P; Zhang K
Cancer Chemother Pharmacol; 2009 May; 63(6):1007-16. PubMed ID: 18766342
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and bioevaluation of substituted chalcones, coumaranones and other flavonoids as anti-HIV agents.
Cole AL; Hossain S; Cole AM; Phanstiel O
Bioorg Med Chem; 2016 Jun; 24(12):2768-76. PubMed ID: 27161874
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
Gibson MZ; Nguyen MA; Zingales SK
Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
[TBL] [Abstract][Full Text] [Related]
6. 2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells.
Kim SY; Lee IS; Moon A
Chem Biol Interact; 2013 May; 203(3):565-72. PubMed ID: 23562496
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines.
Abu Bakar A; Akhtar MN; Mohd Ali N; Yeap SK; Quah CK; Loh WS; Alitheen NB; Zareen S; Ul-Haq Z; Shah SAA
Molecules; 2018 Mar; 23(3):. PubMed ID: 29518053
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Activity of Natural and Synthetic Chalcones.
Constantinescu T; Lungu CN
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768736
[TBL] [Abstract][Full Text] [Related]
9. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones.
Cagir A; Odaci B; Varol M; Akcok I; Okur O; Koparal AT
Anticancer Agents Med Chem; 2018 Feb; 17(14):1915-1923. PubMed ID: 28554313
[TBL] [Abstract][Full Text] [Related]
11. Anti-cancer chalcones: Structural and molecular target perspectives.
Mahapatra DK; Bharti SK; Asati V
Eur J Med Chem; 2015 Jun; 98():69-114. PubMed ID: 26005917
[TBL] [Abstract][Full Text] [Related]
12. 5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.
Saito Y; Mizokami A; Tsurimoto H; Izumi K; Goto M; Nakagawa-Goto K
Eur J Med Chem; 2018 Sep; 157():1143-1152. PubMed ID: 30189396
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.
Jeon KH; Yu HB; Kwak SY; Kwon Y; Na Y
Bioorg Med Chem; 2016 Nov; 24(22):5921-5928. PubMed ID: 27707625
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic Effect of Flavonoids and Chalcones: An Update.
Mirossay L; Varinská L; Mojžiš J
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271940
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of prostaglandin E(2) production by synthetic minor prenylated chalcones and flavonoids: synthesis, biological activity, crystal structure, and in silico evaluation.
Rullah K; Mohd Aluwi MF; Yamin BM; Abdul Bahari MN; Wei LS; Ahmad S; Abas F; Ismail NH; Jantan I; Wai LK
Bioorg Med Chem Lett; 2014 Aug; 24(16):3826-34. PubMed ID: 25027933
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and modes of action of 4'-hydroxy-2',6'-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant cancer cell lines.
Kuete V; Nkuete AH; Mbaveng AT; Wiench B; Wabo HK; Tane P; Efferth T
Phytomedicine; 2014 Oct; 21(12):1651-7. PubMed ID: 25442273
[TBL] [Abstract][Full Text] [Related]
17. Chalcones against the hallmarks of cancer: a mini-review.
de Souza PS; Bibá GCC; Melo EDDN; Muzitano MF
Nat Prod Res; 2022 Sep; 36(18):4809-4826. PubMed ID: 34865580
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of methoxy-substituted chalcones and in vitro evaluation of their anticancer potential.
Ethiraj KR; Aranjani JM; Khan FR
Chem Biol Drug Des; 2013 Dec; 82(6):732-42. PubMed ID: 23834620
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in therapeutic applications of chalcones.
Katsori AM; Hadjipavlou-Litina D
Expert Opin Ther Pat; 2011 Oct; 21(10):1575-96. PubMed ID: 21711087
[TBL] [Abstract][Full Text] [Related]
20. Chalcone Derivatives: Role in Anticancer Therapy.
Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
